Skip to content
  1. EMEA Innovative Medicine /
  2. About us /
  3. Our responsibilities /
  4. Sustainability /
  5. Medicines supply

Medicines supply

At Johnson & Johnson, our policy advocacy focuses on supporting strong and resilient global supply chains for medical goods to ensure access for patients, providers, and consumers, even during major public health threats. Our principles are centred around strengthening supply chain diversity and resiliency, safeguarding patient access through the free flow of medical goods, supporting and preparing the manufacturing workforce, and maintaining strategic stockpiles with appropriate products and volumes. We advocate for these policy measures to create efficient supply chains that prioritize patient access, support the healthcare workforce, and enable an effective response to public health challenges. By championing these principles, we aim to ensure uninterrupted access to essential medical goods when they are most needed.
leveraging-supply-chains-to-avoid-medicine-shortages-long-2.png
leveraging-supply-chains-to-avoid-medicine-shortages-long-2.png

To find out more about the importance of global supply chains, Watch Leveraging supply chains to avoid medicine shortages.

CP-516647
May 2025